Americares, in partnership with the Healthcare Distribution Alliance (HDA), has presented its annual Power of Partnership Award to Novartis and its Sandoz division, in recognition of their outstanding commitment to increasing access to health care around the world.
The Healthcare Distribution Alliance (HDA) issued a statement in response to the proposed “Connecticut Option,” which imposes an assessment on the first sale of prescription opioids.
As the logistics experts of the pharmaceutical supply chain, distributors have developed advanced security and monitoring systems to make sure that the medications they handle and transport are authentic and legitimate; secured throughout delivery to avoid tampering or diversion; and received by licensed pharmacies and healthcare providers across the country.
The Healthcare Distribution Alliance (HDA) issued a statement in response to the Minnesota Senate’s passage of HF 400, which imposes annual fees on prescription opioid manufacturers and distributors.
Today, the Healthcare Distribution Alliance (HDA) announced the launch of a new initiative highlighting pharmaceutical distributors’ critical role in the safe, reliable and efficient delivery of medical products to hundreds of thousands of pharmacies, hospitals and other healthcare providers nationwide. The initiative focuses on the work distributors undertake every day, even during the most challenging times, in collaboration with partners across the pharmaceutical supply chain.
